This aptitude for oxidative stress modulation is important in conditions marked by persistent inflammation and immune system anomalies [3, 17]
These legal battles may further involve drug distributors and retailers as defendants, amplifying the magnitude and implications of this emerging issue
Previous studies on the efficacy of oral antihyperglycemic agent triple combination therapy have been, for the most part, conducted with add-on therapy with metformin and sulfonylurea [21]
The protection was mediated through attenuating lipid peroxidation by the scavenging activity of free radicals, as well as the antioxidant activities
79 HelyesZ.ElekesK.SndorK.SzitterI.KereskaiL.PintrE.et al (2010)
The FDA's 2024 safety review noted cases of suicidal thoughts reported in post-marketing surveillance, but the incidence rate and causal link remain unclear